Ong, John, Serra, Maria Paola, Segal, Joe, Cujba, Ana-Maria, Ng, Soon Seng, Butler, Richard, Millar, Val, Hatch, Stephanie, Zimri, Salman, Koike, Hiroyuki, Chan, Karen, Bonham, Andrew, Walk, Michelle, Voss, Ty, Heaton, Nigel, Mitry, Ragai, Dhawan, Anil, Ebner, Daniel, Danovi, Davide, Nakauchi, Hiromitsu, Rashid, S Tamir, Ong Hui Chong, John [0000-0001-5103-7311], Butler, Richard [0000-0002-3885-1332], and Apollo - University of Cambridge Repository
Summary Use of hepatocytes derived from induced pluripotent stem cells (i-Heps) is limited by their functional differences in comparison with primary cells. Extracellular niche factors likely play a critical role in bridging this gap. Using image-based characterization (high content analysis; HCA) of freshly isolated hepatocytes from 17 human donors, we devised and validated an algorithm (Hepatocyte Likeness Index; HLI) for comparing the hepatic properties of cells against a physiological gold standard. The HLI was then applied in a targeted screen of extracellular niche factors to identify substrates driving i-Heps closer to the standard. Laminin 411, the top hit, was validated in two additional induced pluripotent stem cell (iPSC) lines, primary tissue, and an in vitro model of α1-antitrypsin deficiency. Cumulatively, these data provide a reference method to control and screen for i-Hep differentiation, identify Laminin 411 as a key niche protein, and underscore the importance of combining substrates, soluble factors, and HCA when developing iPSC applications., Highlights • iPSC-derived hepatocytes (i-Heps) are functionally limited compared with primary cells • Factors within the extracellular niche likely play a role in bridging this gap • Laminin 411 was shown to be an important niche factor for i-Heps • High content image analysis (HCA) can help development of i-Hep applications, Rashid and colleagues demonstrate the utility of a high-throughput imaging platform for identification of physiologically relevant extracellular niche factors to advance i-Heps closer to their primary tissue counterparts. The extracellular matrix (ECM) protein screen identified Laminin 411 as an important niche factor facilitating i-Hep-based disease modeling in vitro.